首页> 外文期刊>Current allergy & clinical immunology >Allsa research awards report CORTICOSTERO1D RESPONSIVENESS IN ASTHMATIC CHILDREN: COMPARISON BETWEEN 'DIFFICULT-TO-CONTROL' AND 'RESPONSIVE-TO-TREATMENT' ASTHMA - A PILOT STUDY
【24h】

Allsa research awards report CORTICOSTERO1D RESPONSIVENESS IN ASTHMATIC CHILDREN: COMPARISON BETWEEN 'DIFFICULT-TO-CONTROL' AND 'RESPONSIVE-TO-TREATMENT' ASTHMA - A PILOT STUDY

机译:Allsa研究奖报告哮喘儿童中的Corticostero1D反应能力:“难以控制”和“反应能力治疗”哮喘之间的比较 - 一项试点研究

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic asthma, the most common chronic disease in children, affects approximately 20% of children worldwide.1'2 In Africa, the asthma prevalence among children in several centres, including Cape Town and Polokwane, is 18-21.5%, which is similar to that in western Europe.2 Corticosteroids, which have broad anti-inflammatory effects, are the preferred, most effective and cost-effective treatment for asthma.3'4 However, 5-10% of asthmatic patients do not respond well to corticosteroid treatment and are referred to as having 'difficult-to-control' asthma.3-4 These subjects can account for more than 50% of the total health care costs of asthma.4 Patients with 'difficult-to-control' asthma could be relatively insensitive to steroids.3'4 There could, however, be other underlying factors such as poor adherence to medication, incorrect inhaler technique, environmental triggers and co-morbid conditions such as rhinosinusitis, gastro-oesophageal reflux and psychosocial dysfunction.3
机译:慢性哮喘是儿童中最常见的慢性疾病,影响了全球约20%的儿童。1'2在非洲,包括开普敦和波洛克瓦在内的几个中心儿童的哮喘患病率为18-21.5%,类似于 在西欧,具有广泛抗炎作用的2皮质类固醇是哮喘的首选,最有效,最具成本效益 3-4这些受试者可以占哮喘的总医疗保健成本的50%以上。4患者“难以控制”哮喘的哮喘患者可能会相对不敏感 3'4然而,可能还有其他潜在因素,例如对药物的依从性不佳,不正确的吸入技术,环境触发器和鼻鼻涕等合并症状况

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号